NCT05315323View on ClinicalTrials.gov

Clinical Use of EVUSHELD as Pre-exposure Prophylaxis in Real-world Setting in Gulf Cooperation Council Countries

CompletedOBSERVATIONAL
Enrollment

550

Participants

Timeline

Start Date

June 23, 2022

Primary Completion Date

June 27, 2024

Study Completion Date

June 27, 2024

Conditions
COVID-19
Trial Locations (2)

Unknown

Research Site, Abu Dhabi

Research Site, Dubai

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY